Abstract
Tremor of unknown origin is detected in 10–30% of early–treated and in more than 30% late–treated phenylketonuric patients. With the aim of characterizing tremor in phenylketonuria, we carried out a systematic study in 54 patients aged 6 to 37 years. Tremor examination was done by applying the WHIGET Tremor Rating Scale and by accelerometer recording (BYOPAC System MP100WSW). Age at diet onset, IQ test results, concomitant plasma phenylalanine levels and index of dietary control were also studied. Tremor was not observed at rest in any case, but was apparent in 22 patients (40.7%) when carrying out a kinetic task. In 15 patients tremor was also evident during maintenance of a postural task at a frequency ranging between 7.5 and 12.7 Hz. Frequency of tremor was not significantly modified by loading the arms or by increasing muscle contraction. Patients with tremor had a later age at onset of phenylalanine restricted diet (p < 0.001). Other treatment–related variables did not differ between patients with and without tremor. Our results of the neurophysiological examination suggest that tremor in phenylketonuric patients is dependent on a dysfunction of central nervous system networks and may be an index of cerebral damage.
Similar content being viewed by others
References
Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–S120
Brown P, Thompson PD (2001) Electrophysiological aids to the diagnosis of psychogenic jerks, spasms and tremor. Mov Disord 16:595–599
Burlina AB, Bonafé L, Ferrari V, Suppiej A, Zacchello F, Burlina AP (2000) Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment. J Inherit Metab Dis 23:313–316
Cleary MA, Walter JH, Wraith JE, et al. (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87–90
Deuschl G, Raethjen J, Lindemann M, Krack P (2001) The pathophysiology of tremor. Muscle Nerve 24:716–735
Dyer CA (1999) Pathophysiology of phenylketonuria. MRDD Research Reviews 5:104–112
Dyer CA, Kendler A, Philibotte T, et al. (1996) Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol 55:795–814
Elble RJ (1997) The pathophysiology of tremor. In:McGraw–Hill (ed) Movement Disorders. New York, pp 405–417
Evans AH, Costa DC, Gacinovic S, Katzenschlager R, O'Sullivan JD, Heales S, Lee P, Lees AJ (2004) L–Doparesponsive Parkinson's syndrome in association with phenylketonuria: in vivo dopamine transporter and D2 receptor findings. Mov Disord 19:1232–1236
Gassió R, Artuch R, Vilaseca MA, Fusté E, Boix C, Sans A, Campistol J (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninemia: Experience in a pediatric population in Catalonia. Dev Med Child Neurol (in press)
Jervis GA (1937) Phenylpyruvic oligophrenia: introductory study of 50 cases of mental deficiency associated with excretion of phenylpyruvic acid. Arch Neurol Psychiatry 38:944–963
Leuzzi V, Trasimeni G, Gualdi GF, Antonozzi I (1995) Biochemical, clinical and neuroradiological (MRI) correlations in late–detected PKU patients. J Inher Metab Dis 18:624–634
Louis ED, Ottman RA, Ford B, et al. (1997) The Washington Heights essential tremor study: methodologic issues in essential–tremor research. Neuroepidemiology 16:124–133
Louis ED, Barnes L, Wendt KJ, et al. (2001) A teaching videotape for the assessment of essential tremor. Mov Disord 16:89–93
Louis ED, Pullman SL (2001) Comparison of clinical vs. electrophysiological methods of diagnosing of essential tremor. Mov Disord 16:668–673
Malamud N (1966) Neuropathology of phenylketonuria. J Neuropathol Exp Neurol 25:254–268
McDonnell GV, Esmonde TF, Hadden DR, Morrow JI (1998) A neurological evaluation of adult phenylketonuria in Northern Ireland. Eur Neurol 39(1):38–43
Milanov I (2001) Electromyographic differentiation of tremors. Clin Neurophysiol 112:1626–1632
Pedersen HE, Birket–Smith E (1974) Neurological abnormalities in phenylketonuria. Acta Neurol Scand 50:589–594
Pietz J (1998) Neurological aspects of adult phenylketonuria. Curr Opin Neurol 11:679–688
Pietz J, Dunckelmann R, Rupp A, et al. (1998) Neurological outcome in adult patients with early–treated phenylketonuria. Eur J Pediatr 157:824–830
Raethjen J, Lauk M, Köster B, Fietzek U, Friege L, Timmer J, Lücking CH, Deuschl G (2004) Tremor analysis in two normal cohorts. Clin Neurophysiol 115:2151–2156
Scriver CR, Kaufman C, Eisensmith RC, Woo SLC (2001) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th ed, New York:McGraw Hill, pp 1667–1724
Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 116:811–821
Toro C, Cox C, Friehs G, et al. (1994) 8–12 Hz rhythmic oscillations in human motor cortex during two–dimensional arm movements: Evidence for representation of kinematic paremeters. Electroencephalogr Clin Neurophysiol 93:390–403
Toro C, Pascual–Leone A, Deuschl G, et al. (1993) Cortical tremor: A common manifestation of cortical myoclonus. Neurology 43:2346–2353
Villasana D, Buthler IJ, Williams JC, Roongta SM (1989) Neurological deterioration in adult phenylketonuria. J Inher Metab Dis 12:451–457
Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84:411–415
Williams K (1998) Benefits of normalizing plasma phenylalanine: Impact on behaviour and health. A case report. J Inher Metab Dis 21:785–790
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pérez–Dueñas, B., Valls–Solé, J., Fernández–Alvarez, E. et al. Characterization of tremor in phenylketonuric patients. J Neurol 252, 1328–1334 (2005). https://doi.org/10.1007/s00415-005-0860-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0860-6